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Abstract
Tuberculosis still remains the leading cause of death worldwide. The morbidity has been reported 
to decrease, but incident and prevalence of multi-drug resistance Tuberculosis is still on rise. Ri-
fampicin and isoniazid are the first line treatment to TB patients and resistance to these drugs has 
been linked to mutations in genes such as rpoB and katG. In the present study, PCR method was 
employed to detect three types of restricted genes associated with drug resistance tuberculosis 
namely rpoB, regulatory-inhA and katG. Sixty-two samples were obtained from different parts of 
Malaysia hospital which consisted of 35 pulmonary and 27 extra-pulmonary specimens. Twenty-
seven specimens showed positive results as detected by duplex PCR method whereas 3 speci-
mens positive as detected by acid fast bacilli and culture method. Out of 27 isolates, 3 isolates from 
culturable isolates harbored restricted genes that where associated with drug resistance tuberculo-
sis. The mutations involved in rpoB genes comprised of acid amino transposition (isolate 148) and 
frameshift mutations (isolate 624 and 374). This study is clinically important because it focuses in 
molecular diagnosis and can act as an early warning on the emerging status of multidrug resis-
tance of M. tuberculosis in Malaysia. 
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1. Introduction
Tuberculosis (TB) is an infectious bacterial disease caused by Mycobacterium tuberculosis which 
commonly affects the lungs and respiratory system. The TB morbidity was reported decreasing, 
but its remains alarming due to increase in incidence and prevalence of Multi Drug Resistance-TB 
(MDR-TB) [1]. To date, seven antimicrobial agents that have been used in the treatment of resistant 
TB cases were; - isoniazid, rifampicin, pyraxinamide, enthambutol, streptomycin and fluoroqui-
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nolones. MDR phenotype is defined as resistance at least to isoniazid and rifampicin which is the 
most effective drug recommended by World Health Organization (WHO) and being used as the 
first line treatment in TB patient. Therefore, resistance towards these two drugs has become major 
problems in the treatment of TB patients. Resistance to first line anti-TB drugs has been linked to 
mutations in at least 10 genes; katG, inhA, ahpC, kasA and ndh for INH resistance; rpoB for RIF re-
sistance, embB for EMB resistance, pncA for PZA resistance and rpsL and rrs for STR resistance [2]. 
Nevertheless, nearly 95% of the RIF resistant strains possess a mutation in the rpoB gene encoding 
a DNA-dependent RNA polymerase [3]. In addition, approximately 90% of INH resistant strains 
have a mutation in the inhA, katG, and ahpG genes encoding enzymes that are related to mycolic 
acid synthesis of cell wall [3]. Rapid development of drug resistance caused by M. tuberculosis has 
led to measure resistance accurately and easily. This knowledge will certainly help us to under-
stand how to prevent the occurrence of drug resistance as well as identifying genes associated 
with new drug resistance. Keeping the above facts in mind, the present, this study was carried out 
to detect resistance-associated mutations gene in M. tuberculosis clinical isolates.
2. Materials and methods 
2.1. Bacterial isolates and clinical samples 
Bacterial samples used in this study were collected from various hospitals in Malaysia. Prior 
ethical approval was obtained from the institutional ethics committee. The samples consisted of 
pulmonary (n=35) and non-pulmonary (n=27) specimens. The samples such as sputum, gastric 
lavage and urine were decontaminated with 4% NaOH for 15 minutes before being used. All 
samples were investigated for the presence of acid-fast bacilli by Ziehl-Neelsen and cultured on 
Loewenstein-Jensen medium. M. tuberculosis strain ATCC 27294 was grown in Ogawa medium 
and used as positive control. Whereas, Bacillus subtilis (ATCC 26633) was grown on blood agar 
and used as negative control. 
2.2. DNA extraction, PCR amplifications and DNA sequencing analysis 
Extraction of DNA from bacterial culture and clinical samples were carried out by using High 
Pure Viral Nucleic Acid Extraction Kit (Roche Inc. USA) according to manufacturer’s recom-
mendation. DNA from all bacterial isolates and clinical samples were subjected to Duplex-PCR 
using mixture of primers to amplify the IS6110 gene and p53 gene as previous report [4] with 
some modifications. The amplification mixture consisted of 1 μg of template DNA, 1X final con-
centration of MasterMix (Eppendorf), and primers (0.4 pmole/μl). Amplification was carried out 
using Master Cycler Gradient Thermocycler (Eppendorf). The cycling parameters were 94 ºC 
for 3 min followed by 34 cycles of denaturation at 94 ºC for 15 seconds, annealing at 66 ºC for 15 
seconds and extension at 72 ºC for 20 seconds. Final extension was then carried out at 72 ºC for 3 
min. The PCR product was analysed by a 1.6 % agarose gel. Primers used for detection of rpoB, 
inhA and katG resistance genes were design by Vector NTI software. The amplification mixture 
consisted of 1 μg of template DNA, 1X final concentration of MasterMix (Eppendorf), and prim-
ers (0.4 pmole/μl). The amplification was carried out using Master Cycler Gradient Thermocycler 
(Eppendorf). The cycling parameters were 95 ºC for 3 min followed by 34 cycles of denaturation 
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at 95 ºC for 30 seconds, annealing for 30 seconds at 64, 63, and 65 ºC for inhA, rpoB and katG 
respectively.The extension cycle were72 ºC for 90 seconds for inhA and katG genes whereas 60 
seconds for rpoB genes. The final extension was carried out at 72 ºC for 5 min. The PCR product 
was analysed by a 1.6 % agarose gel. DNA fragments of PCR products were purified using QIA-
quick PCR Purification Kit (QIAGEN, Germany) according to manufacturer’s recomendation. 
Purified DNA fragments were sent to the 1st Base Laboratories Sdn. Bhd, Petaling Jaya, Kuala 
Lumpur for sequencing. DNA sequences were analyzed using BLAST (http://www.ncbi.nlm.
nih.gov/BLAST). Multiple sequence alignments were conducted using ClustalW (http://www.
genome.jp/tools/clustalw/). 
3. Result and Discussion
3.1. Detection of M. tuberculosis by PCR and culture method 
In total, 27 extra-pulmonary and 35 pulmonary clinical specimens were obtained for AFB smear, 
culture and PCR analysis. Out of 62 isolates, only 3 isolates namely 148, 374 and 624 were culture 
positive as detected by AFB. The culture was then confirmed as M. tuberculosis complex using 
GenProbe System performed by Bacteriology Unit, National Public Health Laboratory at Sungai 
Buloh, Kuala Lumpur. Nevertheless 27 isolates were positive for IS6110 of M. tuberculosis as de-
tected by DPCR. Of the 27 isolates, 12 of them were from extra-pulmonary isolates and 15 were 
from pulmonary isolates (Figure 1). It was interesting to note that the PCR methods were able to 
detect the AFB negative of the non-pulmonary specimens such as from CSF, bone biopsy, lumbar 
puncture, rectal biopsy and lymph nodes. A similar result was shown by Suhaila et al. (2008) [4]. 
Number of positive isolates detected by PCR analysis was higher compared to culture method. 
Time required for detection of M. tuberculosis from clinical specimens via PCR analysis was less 
than 4 hours whereas more than 8 weeks were required in culture method. 
3.2. Detection of resistance genes 
Out of 27 isolates positive for M. tuberculosis genes, only 3 culturable isolates showed amplifica-
tion of all resistance genes tested (Figure 2). Low quantity of M. tuberculosis DNA in the clini-
cal sample and the presence of inhibitor [5] might be the contributed factors. It was interesting 
to note that all the positive samples bearing the Zielhl Neelson staining scores more that 10/3L 
directly showed the high bacteria numbers. Approximately 104 organisms/ml are required for 
reliable detection with Ziehl-Neelsen stains [6] In addition, the properties of the genes of interest 
also affect the success of amplification. Only one specific site of katG, rpoB and regulatory-inhA 
genes presence in the genome of M. tuberculosis and may explain the limited excess to the genes. 
Hence, the amplification cannot be made. The primer used for detection of resistance genes have 
been successfully design by Vector NTI software. Amplification of resistance genes from clinical 
specimen have been succeeding in three isolates namely 148, 374 and 624. Amplified genes for 
rpoB, katG and inhA were shown in Figure 2a, 2b and 2c respectively. The product size for rpoB, 
katG and inhA were 442bp, 2206bp and 442bp, respectively as confirmed by sequencing analysis.
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Figure 1. Agarose gel showing amplification of p53 and ISP6110. Amplifications were performed using 
marker 100 bp (M) and DNA from M. tuberculosis ATCC 27294 (P), various isolate (1-5), negative control, B. 
subtilis (N), positive control (PP).
Figure 2. Amplification of rpoB gene (a), katG gene (b) and inhA gene (c) From left; Lane HL: Hyperladder 
maker, Lane 1, isolate 148; Lane 2, isolate 374; Lane 3, isolate 624; Lane B, negative control, Lane P, positive 
controlMutation analysis 
PCR products amplified from regulatory-inhA, rpoB and katG genes of M. tuberculosis were se-
quenced with the same primer used in amplification of the genes. The sequences obtained were 
compared to the sequences available in Gen Bank Data using BlastN analysis. The DNA nucleo-
tide sequences were translated to amino acid sequences through BlastX software available in 
http://www.ncbi.nlm.nih.gov. The nucleotide and amino acid changes of each isolates for respec-
tive genes were compared using ClustalW (Vector NTI). As for mutation analysis of rpoB genes, 
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isolate 148 showed minor mutation where the additional, changes and transposition of certain 
base of amino acid Whereas, isolate 374 showed showed frameshift mutation in which total loss 
of A base that subsequently affects the rest of amino acid coding. It is known as.. Nevertheless, 
isolate 624 showed both minor and major mutation at different base position in which all amino 
acid code was totally changed. 
4. Conclusion 
Two isolates of 624 and 374 showed frameshift mutations in which all the amino acid codes were 
totally changed. the quantity of DNA and the present of inhibitor may affect the successful of am-
plification. In addition, only one specific site of katG, rpoB and inhA sequence in whole genome 
of M. tuberculosis.. As for conclusion, the identification of M. tuberculosis through amplification of 
IS6110 was successfully achieved whereas amplification of restricted genes associated with drug 
resistance was achieved in culturable clinical specimens.
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